ABBV

AbbVie Inc Stock Analysis

NEW YORK STOCK EXCHANGE, INC. · Biotechnology

$216.49

▼ -2.14%

Latest quote · typically 15 min delayed

$221.37

Open

$222.35

High

$215.37

Low

$221.23

Prev close

$382.49B

Market cap

Guests get 2 analyses/day. .

What you get with ImpliedLens

📊

Financial statements

Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.

🧮

DCF valuation

Customizable discounted cash flow model with live inputs.

🎯

Analyst targets

Price targets, recommendation breakdowns, earnings surprises.

🏦

Institutional context

Ownership data and aggregated FINRA OTC activity.

📋

SEC filings

Direct links to 10-K, 10-Q, 8-K, and proxy statements.

📈

Projection models

Bull/base/bear scenario modeling with editable assumptions.

01Can AbbVie Inc sustain growth and margins as its technology market matures?

02Which risks would invalidate the investment thesis for ABBV?

03How does ABBV's valuation compare with its growth, quality, and closest alternatives?